他汀类药物的抗心律失常作用
Anti-arrhythmia effect of statins
摘要
随着临床药理学的研究进展,发现许多非抗心律失常药物具有抗心律失常的作用,且已被临床实践所证实.以往曾有许多非抗心律失常药物用于心律失常的治疗,如硫酸镁治疗房扑、房颤、室上速、室速等,辅酶Q10用于房早、室早,ATP用于阵发性室上速,烟酰胺用于病窦、房室传导阻滞,小檗碱用于房早、室早、室上速等.
出处
《临床药物治疗杂志》
2005年第4期29-31,共3页
Clinical Medication Journal
参考文献14
-
1[1]Ridker PM, Rifai N, Lowenthal SP. Rapid reduction in C - reactive protein with cerivastatin among 785 patients with primary hypercholesterolemia. Circulation,2001,103 (9): 1191 ~ 1193
-
2[2]Nissen SE,Tuzcu EM,Schoenhagen P,et al. Statin therapy,LDL cholesterol, C - reactive protein, and coronary artery disease. N Engl J Med,2005 Jan 6,352( 1 ) :29 ~38
-
3冯胜民,史美甫.他汀类药物非降脂作用临床研究进展[J].中国药业,2001,10(12):1-3. 被引量:2
-
4[4]Diomede L, Albani D, Sottocorno M, et al. In Vivo Antiinflammatory Effect of Statins is Mediated by Nonsterol Mevalonate Products. Arteriscler Thromb Vase Biol,2001,21:1327 ~ 1332
-
5[5]Aviram M, Hussein O, Mira R. Interaction of platelets, macrophage and lipoproteins in hypercholesterolemia:Antiatherogenic effects of HMG - CoA reductase inhibitor therapy. J Cardiavasc Pharmacol, 1998,31: 39 ~ 45
-
6[6]Shunji Hayashidani, Hiroyuki Tsutsui, Tetsuya Shiomi, et al. Fluvastatin,a 3 - Hydroxy - 3 - Methylglutaryl Coenzyme A Reductase Inhibitor, Attenuates Left Ventricular Remodeling and Failure After Experimental Myocardial Infarction. Circulation,2002,105: 868 ~ 873
-
7[7]Takemoto M,Grimm M, Takemoto Y, et al. HMG - CoA reductase inhibitors attenuate angiotensin - Ⅱ induced cardiac hypertrophy. Circulation, 2000,102 ( suppl. 2 ): S133
-
8[8]Schwartz G G, Olsson A G, Ezekowitz M D, et al. Effect of atorvastatin on early recurrent ischemia events in acute coronary syndrome, The MIRACL Study, A randomized clinical trial. JAMA,2001,285 ( 3 ): 1771 ~ 1778
-
9曾群英,高修仁,许庆,王强,郑东诞,陶军,廖新学,陈国伟.急性冠状动脉综合征早期应用阿托伐他汀治疗的作用和安全性的临床研究[J].中西医结合心脑血管病杂志,2004,2(4):234-237. 被引量:2
-
10陈定,孔繁荣,赵坚.辛伐他汀对老年冠心病患者QT离散度的影响[J].实用老年医学,2000,14(3):163-164. 被引量:2
二级参考文献31
-
1Keogh A,Macdonald P,Kan A,et al. Efficacy and safety of pravastatin vs simvastatin after cardiac transplantation[J]. J Heart- Lung Transplant, 2000,19(6) :529 - 537.
-
2Wanner C, Quaschning T, Weingarntern K. Impact of dyslipidaemia in renal transplant recipients[J]. Curr Opin Urol,2000,10(2):77-80.
-
3Chan KA, Andrade SE, Boles M, et al. Inhibitors of hydroxymethyl glutaryl- coenzyme A reductase and risk of fracture among older women[J]. Lancet,2000,355:2 185 - 2 188.
-
4Wang PS, Solomon DH, Mogun H,et al. HMG- CoA reductase inhibitor and the risk of hip fracture in elder patients[J]. JAMA,2000,283(24):3211 -3216.
-
5Sugiyama M,Kodama T,Lonishi K,et al. Compactin and simvastatin,but not pravastatin ,induce bone myophogenetic protein- 2 in human osteosarcoma cell[J]. Biochem Biophys Res Commun,2000,271 (3):688 - 692.
-
6Jick H,Zornberg GL,Jick SS,et al. Statin and the risk of dementia[J].Lancet, 2000,356:1 627 - 1 631.
-
7Wolozin B, Keuman W, Roussean P, et al. Decreased prevalence of Alzheimer' s disease associated with 3- hydroxy- 3- menthy-lglutaryl coenzyme A reductase inhibitors[J]. Arch Neurol,2000,57:1439 - 1443.
-
8Oda H, Heane WF. Recent advance in statins and the kidney[J].idney Int, 1999, 56 (supp31 ): s2 - 5.
-
9Aviram M, Hussein O, Mira R. Interaction of platelets, macrophage and lipoproteins in hypercholesterolemia: Antiatherogenic effects of HMGCoA reductase inhibitor therapy [ J ]. J Cardiavasc Pharmacol, 1998,31:39 - 45.
-
10Barrow N,Stratton PD,Benjiamin N. Reduction of LDL cholesterol by pravastatin does not influence platelet action in patient with mild hyercholesterolaemia at risk of coronary heart disease[J]. Br J ClinPharmacol, 1991,32:127 - 129.
共引文献15
-
1林星虹.心力衰竭治疗的现代认识[J].中国医学文摘(内科学),2004(3):385-387.
-
2廖继全.阿托伐他汀治疗不稳定型心绞痛疗效观察[J].右江医学,2005,33(2):121-122. 被引量:2
-
3黎忠于,胡建新.他汀类药物在心血管病方面的应用进展[J].江西医药,2005,40(12):860-862. 被引量:2
-
4汤益明,吴跃进,哈志强.循证医学与中西医结合[J].实用中西医结合临床,2006,6(6):84-86.
-
5张蔚君,梁贵键,朱莉,张福成.他汀类药物临床治疗作用研究新进展[J].空军总医院学报,2006,22(4):212-217. 被引量:1
-
6杨栋,张剑宇.红曲治疗原发性骨质疏松症研究进展[J].临床医药实践,2007,16(4):245-247.
-
7戴倩,王俊.不稳定型心绞痛治疗进展[J].疑难病杂志,2007,6(8):505-508. 被引量:65
-
8张侨.慢性心力衰竭112例的治疗体会[J].中国现代药物应用,2008,2(9):77-78.
-
9潘金生,刘应才.他汀类药物治疗慢性心力衰竭的研究进展[J].实用医药杂志,2008,25(8):999-1001. 被引量:1
-
10李欣辉.小儿急性心力衰竭的诊治进展[J].华夏医学,2008,21(4):873-875. 被引量:2
-
1凌建胜,徐瑛.非抗心律失常药物治疗心律失常[J].临床荟萃,1995,10(6):268-270. 被引量:4
-
2王聘钦.非抗心律失常药物的抗心律失常作用[J].医学理论与实践,1991,4(2):44-46.
-
3王永斌,张菊慧.某些非抗心律失常药物致心律失常作用[J].张家口医学院学报,1995,12(1):26-28.
-
4杨忠信,侯应龙.非抗心律失常药物在抗心律失常中的应用[J].陕西医学杂志,1995,24(3):169-171.
-
5蒋长盛.非抗心律失常药物的抗心律失常作用[J].现代诊断与治疗,1991,2(4):373-377.
-
6舒永华,田志军.稳心颗粒联合比索洛尔治疗房早、室早、房颤的临床疗效观察[J].海峡药学,2015,27(3):171-172. 被引量:2
-
7李伟扬,李伟强,赵伟,赵晓明,.利多卡因治疗室上性与室性心律失常的疗效[J].黑龙江医药,1993,0(10):25-25.
-
8龙文.心律平治疗阵发性室上速83例疗效分析[J].井冈山医专学报,2005,12(4):37-37.
-
9涂宣庆,詹明权,林兴三,陈鸿友.心律平治疗阵发性室上性心动过速临床观察(附102例分析)[J].海峡药学,2006,18(2):112-113. 被引量:2
-
10孙勇,王建安,何红.腺苷转复阵发性室上速的临床应用观察[J].急诊医学,2000,9(5):322-322. 被引量:2